Within a climate of flourishing technological and capital alliances across borders in the global pharmaceutical industry, Genom Biotech continues to enhance its presence by aggressively developing operations in CIS, Africa, and ASEAN countries. Today, Genom Biotech reaches out to more than 40 countries globally catering to sophisticated markets like US, UK, Europe, and also to semi regulated markets like Eastern Europe, CIS, South East Asia, Middle East, Africa. Our International Operations is focused on:
- Selected high-growth emerging markets
- Multi-product/country, single distributor deals
- Improving partner support
- Penetration into the nutraceutical market
Our international marketing efforts are focused on brand building leveraging on the strong brand recall for our products. A well-knit distribution network, robust supply chain, and quality products ascertain the consumer satisfaction and ultimately a loyal consumer pool. |
